BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 36443754)

  • 1. Enterotypical Prevotella and three novel bacterial biomarkers in preoperative stool predict the clinical outcome of colorectal cancer.
    Huh JW; Kim MJ; Kim J; Lee HG; Ryoo SB; Ku JL; Jeong SY; Park KJ; Kim D; Kim JF; Park JW
    Microbiome; 2022 Nov; 10(1):203. PubMed ID: 36443754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
    Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
    J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
    Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
    Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
    EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut mucosal microbiota profiles linked to colorectal cancer recurrence.
    Huo RX; Wang YJ; Hou SB; Wang W; Zhang CZ; Wan XH
    World J Gastroenterol; 2022 May; 28(18):1946-1964. PubMed ID: 35664963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results.
    Lu F; Lei T; Zhou J; Liang H; Cui P; Zuo T; Ye L; Chen H; Huang J
    J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37288545
    [No Abstract]   [Full Text] [Related]  

  • 7. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
    John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
    J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer.
    Alexander JL; Posma JM; Scott A; Poynter L; Mason SE; Doria ML; Herendi L; Roberts L; McDonald JAK; Cameron S; Hughes DJ; Liska V; Susova S; Soucek P; der Sluis VH; Gomez-Romero M; Lewis MR; Hoyles L; Woolston A; Cunningham D; Darzi A; Gerlinger M; Goldin R; Takats Z; Marchesi JR; Teare J; Kinross J
    Microbiome; 2023 May; 11(1):100. PubMed ID: 37158960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metronidazole on colorectal cancer occurrence and colorectal cancer liver metastases by regulating Fusobacterium nucleatum in mice.
    Wang M; Li Y; Yang X; Liu Z; Wang K; Gong D; Li J
    Immun Inflamm Dis; 2023 Nov; 11(11):e1067. PubMed ID: 38018574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer.
    Yao Q; Tang M; Zeng L; Chu Z; Sheng H; Zhang Y; Zhou Y; Zhang H; Jiang H; Ye M
    BMC Microbiol; 2021 May; 21(1):156. PubMed ID: 34044781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers.
    Dai Z; Coker OO; Nakatsu G; Wu WKK; Zhao L; Chen Z; Chan FKL; Kristiansen K; Sung JJY; Wong SH; Yu J
    Microbiome; 2018 Apr; 6(1):70. PubMed ID: 29642940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.
    Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M
    Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer.
    Ohashi A; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Fujishiro M
    Digestion; 2022; 103(6):451-461. PubMed ID: 36349755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon.
    Zorron Cheng Tao Pu L; Yamamoto K; Honda T; Nakamura M; Yamamura T; Hattori S; Burt AD; Singh R; Hirooka Y; Fujishiro M
    J Gastroenterol Hepatol; 2020 Mar; 35(3):433-437. PubMed ID: 31609493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.
    Kasai C; Sugimoto K; Moritani I; Tanaka J; Oya Y; Inoue H; Tameda M; Shiraki K; Ito M; Takei Y; Takase K
    Oncol Rep; 2016 Jan; 35(1):325-33. PubMed ID: 26549775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
    Huh JW; Roh TY
    BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-associated and non-tumour-associated microbiota: Addendum.
    Flemer B; Herlihy M; O'Riordain M; Shanahan F; O'Toole PW
    Gut Microbes; 2018 Jul; 9(4):369-373. PubMed ID: 29420132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Fecal
    Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
    Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
    Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
    Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between Intestinal Microbiota and Clinical Characteristics in Colorectal Adenoma/Carcinoma.
    Lin C; Li B; Tu C; Chen X; Guo M
    Biomed Res Int; 2022; 2022():3140070. PubMed ID: 35937408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.